SEP 7, 2026 · JOURNAL ARTICLE
Beyond mismatch repair in colorectal cancer liver metastases: rethinking immunotherapy through the hepatic metastatic niche
Frontiers in Immunology
This is a conceptual framework paper proposing mechanistic hypotheses about hepatic disease as a modifier of immunotherapy efficacy in colorectal cancer, without new primary data or definitive evidence.
Reported
Sample size (Pakvisal retrospecti…132
Active liver metastases (Pakvisal)93
Clinical benefit with active live…16.1%